Shares of Clorox (CLX) are taking a hit Thursday after the consumer products giant reported fiscal third-quarter results and lowered its full-year outlook. The stock dropped 6.4% in after-hours trading to $90.30, which would mark a new 52-week low if it holds into Friday's open.

Here's the rundown.

Q3 by the Numbers

Clorox reported third-quarter revenue of $1.67 billion, flat compared to the same period last year. Organic sales slipped 1% year-over-year. That was enough to edge past the Street consensus estimate of $1.667 billion, according to market data.

Earnings per share came in at $1.64, beating the consensus estimate of $1.55.

CEO Linda Rendle described the quarter as mixed: "Our third-quarter results were mixed, with continued momentum in some parts of our portfolio and slower-than-anticipated market share recovery in others."

Segment performance varied widely:

• Health and Wellness (Cleaning, Professional Products): net sales flat
• Household (Bags and Wraps, Cat Litter, Grilling): net sales up 3% year-over-year
• Lifestyle (Food, Water Filtration, Natural Personal Care): net sales down 9% year-over-year
• International: net sales up 8% year-over-year

Guidance Gets a Trim

The bigger story is the outlook. Clorox now expects full-year fiscal 2026 net sales to be down 6% year-over-year. More notably, the company slashed its adjusted earnings per share guidance from a prior range of $5.95 to $6.30 to a new range of $5.45 to $5.65. That's well below the current Street consensus of $5.89.

Management pointed to three factors behind the revision: shipping inventory ahead of consumption in the fourth quarter of 2025, the impact of the GOJO acquisition, and a negative effect on net sales from the divestiture of the VMS vitamins business.

"We recognize there is more work to do in what continues to be a challenging consumer and cost environment," Rendle said. "We're focused on improving execution to accelerate market share progress in challenging areas while continuing to invest behind areas of strength."

Stock Under Pressure

Clorox shares have been sliding for a while. The stock's 52-week range is $95.11 to $143.96, and Thursday's after-hours move puts it below that lower bound. If the losses hold, Friday's open would be a new 52-week low.

Investors are clearly worried about the company's ability to regain momentum in a tough consumer environment. The guidance cut suggests that the road ahead may be bumpier than expected.